LLY - Fusion Pharma gains as Raymond James upgrades on radiopharma M&A
2023-12-27 11:03:53 ET
More on Fusion Pharmaceuticals
- RBC says Bristol Myers/RayzeBio deal validates Fusion 's approach
- Fusion Pharma shares jump following expanded actinium supply deal with BWXT
- Seeking Alpha’s Quant Rating on Fusion Pharmaceuticals
- Historical earnings data for Fusion Pharmaceuticals
- Financial information for Fusion Pharmaceuticals
For further details see:
Fusion Pharma gains as Raymond James upgrades on radiopharma M&A